← Back to Vaccine Database

CMV-MVA Triplex

Live attenuated vaccine · VDDBV0160

Target & Classification

CMVCytomegalovirus
Live attenuated vaccine
Cytomegalovirus Infections
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT05099965 Phase 2Cytomegalovirus Infections
NCT01941056 Phase 1Cytomegalovirus Infections